Finzati - Logo
RGEN logo

Repligen Corporation

RGEN • Medical - Instruments & Supplies
$167.60
▼ -2.01 (-1.19%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$8.10B
Growth
6.3%
Cash Flow
5/5
Trend
Stable
Evidence
Positive free cash flow · 1.67Consistent free cash flow · 5/5Manageable debt level · 0.33Healthy liquidity · 8.37Expensive earnings multiple · 188.46
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$167.60
Change-1.19%
Market Cap$8.10B
52W Range100.99 - 175.77
Beta1.06
Gross Margin47.09%
Oper. Margin8.07%
Profit Margin6.62%
Debt/Eq0.33
Current Ratio8.37
Quick Ratio7.12
Revenue 5Y6.32%

Investment DNA

How strong this company looks for long-term investors

58
out of 100
Business Quality
Margins, moat, returns
40/100
Financial Strength
Debt, cash, stability
77/100
Growth Potential
Revenue and expansion
67/100
Price Attractiveness
Cheap or expensive today
29/100
Why this score▼
Positive free cash flow · 1.67Consistent free cash flow · 5/5Manageable debt level · 0.33Healthy liquidity · 8.37Expensive earnings multiple · 188.46

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-07-31
Low
$142.00
Mean
$152.00
Median
$152.50
High
$160.00

Company Overview

IPO: 4/29/1986
Industry: Medical - Instruments & Supplies
P/B i: 4.38
Debt / Equity i: 0.33
Operating Margin: 8.07%
Net Margin: 6.62%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.33
Current Ratio: 8.37
Quick Ratio: 7.12
Status: Good

Insider Transactions

Recent executive and insider activity

Garland Jason K
Transaction: 07/16/2026
SELL
Change
-530
Price
$150.00
Filing
07/17/2026
Type
SELL
Garland Jason K
Transaction: 06/25/2026
SELL
Change
-733
Price
$145.00
Filing
06/26/2026
Type
SELL
BARTHELEMY NICOLAS
Transaction: 05/14/2026
BUY
Change
+2,239
Price
$103.38
Filing
05/18/2026
Type
BUY